We Have Already Almost Solved Aging.
For decades, science viewed aging as irreversible hardware damage. The paradigm has shifted. Aging is a software glitch—and the cell remembers how to reset itself.
Rewriting The Code of Aging
Watch the AI deep dive into how epigenetic reprogramming is turning science fiction into clinical reality.
The Yamanaka Factors
In 2006, Shinya Yamanaka won the Nobel Prize for discovering four factors (OSKM) that convert adult cells back into stem cells.
But total reprogramming erases cellular identity. Harvard's David Sinclair discovered the solution: Partial Reprogramming.
By dropping the c-Myc oncogene and using only OSK, cells roll back to a youthful state without losing identity.
Trigger The Reset
OSK therapies are controlled via a doxycycline switch. Flipping it strips away epigenetic noise—the exact methylation marks that accumulate with age.
The ER-100 Breakthrough
Sinclair's Nature (2020) paper proved OSK can reverse vision loss. Now, it's moving to the clinic. Life Biosciences received FDA clearance in 2026 for Phase 1 human trials of ER-100, targeting optic neuropathies.